undamentalytics Newsletter

Harrow, Inc. income statement

In fiscal 2025, Harrow, Inc. reported revenue of $272m, up 36.4% on the year before, operating income of $30.5m (a 11.2% margin) and net income of −$5.1m, or −$0.14 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Harrow, Inc.: income statement, annual
Fiscal year2013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue021020274151497289130200272276
Cost of revenue————14171714182540496874
Gross profit0151013253434546391150204202
Research and development200101221137122129
Selling, general and administrative6———25293331415883129153176
Selling and marketing—267——————————
General and administrative—81318——————————
Operating income−8−10−15−16−12−5−50220931−3
Interest expense—0——————5721232423
Net interest income—0−1−3−3−3−3−2−5—————
Income before tax———−19−1315−0−3−18−14−24−17−1−33
Income tax—00−0−1—0000104—
Net income−8−10−16−19−12150−3−18−14−24−17−5−37
Diluted EPS−$0.88−$1.11−$1.66−$1.50−$0.60$0.61$0.01−$0.13−$0.69−$0.51−$0.75−$0.49−$0.14−$1.01
Diluted shares (average)9m9m10m13m20m24m26m26m27m27m33m36m37m37m
EBITDA−8−10−15−15−11−4−323311032−1

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: EOLS vs HROWACB vs HROWHROW vs VNDAHROW vs XERS

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Harrow, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Harrow, Inc.